NO20006507L - Propenyl kefalosporinderivater - Google Patents
Propenyl kefalosporinderivaterInfo
- Publication number
- NO20006507L NO20006507L NO20006507A NO20006507A NO20006507L NO 20006507 L NO20006507 L NO 20006507L NO 20006507 A NO20006507 A NO 20006507A NO 20006507 A NO20006507 A NO 20006507A NO 20006507 L NO20006507 L NO 20006507L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen
- carbon
- sulfur
- nitrogen
- exceeding
- Prior art date
Links
- 229930186147 Cephalosporin Natural products 0.000 title abstract 2
- 229940124587 cephalosporin Drugs 0.000 title abstract 2
- -1 Propenyl cephalosporin Chemical class 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 102100034741 Cyclin-dependent kinase 20 Human genes 0.000 abstract 1
- 101500014379 Lymnaea stagnalis Ovulation hormone Proteins 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001780 cephalosporins Chemical class 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/40—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by an aliphatic carboxylic acid, which is substituted by hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98111415 | 1998-06-22 | ||
| EP99108149 | 1999-04-26 | ||
| PCT/EP1999/004034 WO1999067255A1 (en) | 1998-06-22 | 1999-06-11 | Propenyl cephalosporin derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006507D0 NO20006507D0 (no) | 2000-12-20 |
| NO20006507L true NO20006507L (no) | 2000-12-20 |
Family
ID=26149364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006507A NO20006507L (no) | 1998-06-22 | 2000-12-20 | Propenyl kefalosporinderivater |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6583133B1 (tr) |
| EP (1) | EP1090013A1 (tr) |
| JP (1) | JP4033630B2 (tr) |
| KR (1) | KR100414336B1 (tr) |
| CN (1) | CN1173979C (tr) |
| AU (1) | AU761450B2 (tr) |
| BR (1) | BR9911445A (tr) |
| CA (1) | CA2335288A1 (tr) |
| HU (1) | HUP0102350A2 (tr) |
| ID (1) | ID28433A (tr) |
| IL (1) | IL140010A0 (tr) |
| MA (1) | MA26657A1 (tr) |
| NO (1) | NO20006507L (tr) |
| PL (1) | PL345266A1 (tr) |
| TR (1) | TR200003807T2 (tr) |
| WO (1) | WO1999067255A1 (tr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020085176A (ko) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | 신규 세팔로스포린계 항생제 및 이의 제조 방법 |
| KR20020085180A (ko) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | 신규 세팔로스포린계 항생제 및 이의 제조 방법 |
| ITRM20020014A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
| KR100693298B1 (ko) * | 2003-06-27 | 2007-03-13 | 영진약품공업주식회사 | 신규한 세팔로스포린계 화합물 및 약제학적으로 허용되는염과 그의 제조 방법 |
| TW200637559A (en) * | 2005-03-29 | 2006-11-01 | Shionogi & Co | 3-propenylcefem derivative |
| DK2893929T3 (da) | 2013-03-15 | 2025-07-07 | Merck Sharp & Dohme Llc | Antibiotisk ceftolozansammensætninger |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3983113A (en) * | 1975-08-15 | 1976-09-28 | Syntex (U.S.A.) Inc. | Cephalosporin type antibacterials |
| US4486586A (en) | 1983-02-10 | 1984-12-04 | Bristol-Myers Company | Cephalosporin derivatives |
| US4751295A (en) | 1984-04-09 | 1988-06-14 | Bristol-Myers Company | Cephalosporin derivatives |
| CA1276929C (en) | 1984-04-09 | 1990-11-27 | Masahisa Oka | Cephalosporin antibacterial agents |
| FR2622585B1 (fr) | 1987-11-03 | 1991-04-19 | Roussel Uclaf | Nouvelles cephalosporines comportant en position 3 un radical vinyle substitue, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus |
| DE68929368T2 (de) * | 1988-03-16 | 2002-08-14 | Eisai Co., Ltd. | Cephemderivate und Verfahren zu ihrer Herstellung |
| ES2157199T3 (es) | 1991-03-08 | 2001-08-16 | Biochemie Gmbh | Nuevo procedimiento para la produccion de cefalosporinas y nuevos compuestos intermedios para este procedimiento. |
| AT396108B (de) * | 1991-08-21 | 1993-06-25 | Biochemie Gmbh | Neues verfahren und neue zwischenprodukte zur herstellung von 7-aminocephalosporansaeurederivaten |
| US5523400A (en) * | 1993-04-16 | 1996-06-04 | Hoffmann-La Roche Inc. | Cephalosporin antibiotics |
| CA2143519A1 (en) * | 1994-03-11 | 1995-09-12 | F. Hoffmann-La Roche Ag | Beta-lactams |
| CZ251896A3 (en) * | 1995-09-12 | 1997-04-16 | Hoffmann Ka Roche Ag F | Cephalosporin derivatives |
| ES2281090T3 (es) | 1996-11-06 | 2007-09-16 | Basilea Pharmaceutica Ag | Derivados de vinilpirrolidona-cefalosporina. |
| US6150350A (en) * | 1997-09-15 | 2000-11-21 | Hoffman-La Roche Inc. | Antimicrobial compositions |
-
1999
- 1999-06-11 JP JP2000555907A patent/JP4033630B2/ja not_active Expired - Fee Related
- 1999-06-11 IL IL14001099A patent/IL140010A0/xx unknown
- 1999-06-11 CN CNB998077682A patent/CN1173979C/zh not_active Expired - Fee Related
- 1999-06-11 WO PCT/EP1999/004034 patent/WO1999067255A1/en not_active Ceased
- 1999-06-11 HU HU0102350A patent/HUP0102350A2/hu unknown
- 1999-06-11 EP EP99929182A patent/EP1090013A1/en not_active Withdrawn
- 1999-06-11 TR TR2000/03807T patent/TR200003807T2/tr unknown
- 1999-06-11 CA CA002335288A patent/CA2335288A1/en not_active Abandoned
- 1999-06-11 ID IDW20010140A patent/ID28433A/id unknown
- 1999-06-11 AU AU46081/99A patent/AU761450B2/en not_active Ceased
- 1999-06-11 BR BR9911445-3A patent/BR9911445A/pt not_active IP Right Cessation
- 1999-06-11 KR KR10-2000-7014573A patent/KR100414336B1/ko not_active Expired - Fee Related
- 1999-06-11 PL PL99345266A patent/PL345266A1/xx unknown
- 1999-06-21 MA MA25640A patent/MA26657A1/fr unknown
- 1999-06-22 US US09/337,908 patent/US6583133B1/en not_active Expired - Fee Related
-
2000
- 2000-12-20 NO NO20006507A patent/NO20006507L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2335288A1 (en) | 1999-12-29 |
| AU4608199A (en) | 2000-01-10 |
| JP4033630B2 (ja) | 2008-01-16 |
| HUP0102350A2 (hu) | 2001-11-28 |
| CN1173979C (zh) | 2004-11-03 |
| TR200003807T2 (tr) | 2001-06-21 |
| JP2002518505A (ja) | 2002-06-25 |
| WO1999067255A1 (en) | 1999-12-29 |
| ID28433A (id) | 2001-05-24 |
| NO20006507D0 (no) | 2000-12-20 |
| AU761450B2 (en) | 2003-06-05 |
| CN1306536A (zh) | 2001-08-01 |
| US6583133B1 (en) | 2003-06-24 |
| MA26657A1 (fr) | 2004-12-20 |
| IL140010A0 (en) | 2002-02-10 |
| KR20010053092A (ko) | 2001-06-25 |
| PL345266A1 (en) | 2001-12-03 |
| EP1090013A1 (en) | 2001-04-11 |
| KR100414336B1 (ko) | 2004-01-07 |
| BR9911445A (pt) | 2001-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE353870T1 (de) | Dibenzylaminverbindung und deren medizinische verwendung | |
| NO20054224L (no) | Nye 2-pyridinkarboksamidderivater | |
| NO20015447L (no) | Kinolinderivater som inhibitorer av MEK enzymer | |
| NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
| DK0625977T3 (da) | Piperazinderivater som 5-1A-antagonister | |
| HUP0203122A2 (hu) | Fab I inhibitorok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE3868301D1 (de) | 2-(methyl(4-piperidinyl))-1,2,3,4-tetrahydro-9h-pyrido(3,4-b)indolderivate, ihre herstellung und therapeutische verwendung. | |
| HUP0401886A2 (hu) | Kemokin receptor aktivitás modulátorokként alkalmazható piperidinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| PL309874A1 (en) | Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives | |
| DE69227088D1 (de) | Verwendung von 1-(aminoalkyl)-3-Quinoxalin-2-on Derivaten zur Herstellung von neuroprotektiven Mitteln | |
| EA200101224A1 (ru) | Производные пурина, способ их получения и содержащие их фармацевтические композиции | |
| MXPA05013631A (es) | Derivado heterociclico de metilsulfona. | |
| NO166940C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4 (5)-substituerte imidazol-derivater, og mellomprodukttil bruk ved fremstillingen. | |
| NO20006507L (no) | Propenyl kefalosporinderivater | |
| AR003137A1 (es) | Una composicion farmaceutica para tratar la leucemia | |
| EP1156057A4 (en) | MALTO-OLIGOSACCHARID DERIVATIVES AND THEIR APPLICATIONS | |
| HU9600621D0 (en) | Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia | |
| GR3020292T3 (en) | Use of 2-iminothiazolidin-4-one derivatives as new medicaments | |
| DK0556813T3 (da) | Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler | |
| NZ515278A (en) | Halo derivatives of 9-deoxo-9a-aza-9a- homerythromycin A their salts and preparation process | |
| NO944577L (no) | Hemming av effekten av amyloidogene proteiner | |
| MY133207A (en) | Substituted benzolactam compaunds | |
| NO920619L (no) | Oxazinobenzazolforbindelser | |
| DK0570850T3 (da) | Benzo(b)thiophen-3-yl-piperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
| ATE148699T1 (de) | Herstellung von 2-(2-thienyl)äthylamin und synthese von thieno(3,2-c)pyridinderivaten daraus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |